L carnitine Supplementation as Treatment for Cardiac Fibrosis and Heart Failure with Preserved Ejection Fraction Journal of Cardiac Failure L carnitine Supplementation as Treatment for Cardiac Fibrosis and Heart Failure with Preserved Ejection Fraction Myeloperoxidase, carnitine, and derivatives of reactive oxidative metabolites in heart failure with preserved versus reduced ejection fraction: A meta analysis International Journal of Cardiology Intestinal microbiota metabolism of l carnitine, a nutrient in red meat, promotes atherosclerosis Nature Medicine